Scientific Posters

ADLM 2025 FEBS 2025

Skeletal Troponin I Isoforms: In what forms do they exist in human blood?

Development of high-affinity monoclonal antibodies specific to human thyroid stimulating hormone (TSH) that recognize the TSH variant R55G

Human cardiac troponin complex stability in various matrices

Development of the immunochemical systems for specific detection of different forms of human skeletal troponin I

FEBS 2022

Skeletal troponin I detection in the blood of patients with skeletal muscle injury

Influence of heparin on the immunodetection of cardiac troponin

AACC 2020

Diverse short-term natriuretic response in acute decompensated heart failure patients undergoing Entresto™ treatment

2020 ACVP, ASVCP, and ISACP Virtual Annual Meeting

• New immunoassays for the detection of the most common feline serum amyloid A (SAA) variants
  

ISA 2020

• New immunoassays for the selective measurement of serum amyloid A isoforms 1 and 2 in human blood

AACC 2019

• Novel neprilysin-derived BNP fragments in the plasma of heart failure patients suggest possible insights for a guided ARNi therapy
• Full-size human cardiac troponin T and its fragments in the plasma of patients with acute myocardial infarction 
  
• 
  IFCC EuroMedLab Conference 2019
• Cardiac troponins in the blood of patients with acute myocardial infarction: in what forms do they exist?
• Novel neprilysin-derived BNP fragment in the circulation: evidence from a rat model

ISACP 2018

• Recombinant canine C-reactive protein as a reliable calibrator for different types of cCRP assays
  

AACC 2018

• Human cardiac TnI degradation and antibody selection for the assay development
  
• NT-proBNP assays that are based on antibodies which are specific to nonglycosylated regions of NT-proBNP display a similar diagnostic accuracy in distinguishing heart failure patients compared to the Roche NT-proBNP assay
  

Hear Failure Congress 2018

• C-terminal fragment of IGFBP-4 is independently associated with mortality in patients hospitalized due to acute heart failure
  
• Non-hypertrophic and hypertrophic human cardiomyocytes secrete
  unprocessed ANP and BNP precursors (proANP/proBNP) and exhibit a
  similar efficiency in their processing
  

American Heart Association Scientific Sessions 2017

• Pro-Atrial natriuretic peptide (proANP) as a stable circulating ANP form that is not affected by neprilysin-mediated cleavage
  

4th Joint EFLM-UEMS Congress 2016

• Fragmentation of human cardiac troponin I from serum samples of AMI patients
  
• Human cardiac troponin T is cleaved by thrombin in serum samples
  
• N-glycosylated IGFBP-4 could be less susceptible to PAPP-A mediated proteolysis than the non-glycosylated form
  
• Searching for a BNP standard: glycosylated proBNP as a common calibrator enables improved comparability of BNP immunoassays results
  

AACC 2016

• Antibodies and recombinant standards for the Lp-PLA2 fluoroimmunoassay
  
• Different susceptibility of BNP and proBNP to neprilysin cleavage suggests a limited effect of neprilysin inhibition by LCZ696 on the level of immunoreactive BNP
  
• The influence of troponin-specific autoantibodies on measurement of cardiac troponin I in binary and ternary complexes
  
• N-glycosylation of NT-IGFBP-4 does not influence its immunodetection by the neo-epitope specific sandwich immunoassay
  

AACC 2015

• In vitro Studies of Human Cardiac Troponin I Degradation
  

IFCC EuroMedLab Conference 2015

• Processing of human proBNP in serum, EDTA-plasma and heparinized plasma: the matrix defines it all
  

XXV ISTH Congress 2015

• Evaluation of the ratios of high molecular weight fibrin degradation products (HMW FDP) to D-dimer in patients’ blood by the immunoassay equally recognizing D-dimer and HMW FDP
  

ACVIM Forum 2015

• Monoclonal antibodies specific to serum amyloid A from different species
  

AACC 2014

• A step towards D-dimer assays’ standardization: Antibodies with Equal Specificity to D-dimer and High Molecular Weight Fibrin Degradation Products
  

AACC 2013

• Investigation of immunochemical and biochemical properties of circulating IGFBP-4 fragments – novel biomarkers for cardiac risk assessment
  
• Monoclonal antibodies for detection of retinol-binding protein 4
  
• Development of immunoassays for quantification of NT-proBNP in canine blood
  
• N-glycosylated IGFBP-4 could be less susceptible to PAPP-A mediated proteolysis than the non-glycosylated form
  

AACC 2011

• N-terminal and C-terminal fragments of IGFBP-4 as new markers for short-term risk assessment of major adverse cardiac events (MACE) in patients presenting with ischemia
  
• Evidence for processing of human pro-B-type natriuretic peptide in the circulation
  

AACC 2010    

• The Role of Furin and Corin in Processing of Human B-type Natriuretic Peptide Precursor
  
• Sandwich immunoassay prototypes for human LMW adiponectin and for complex of adiponectin with serum albumin
  
• B-type natriuretic peptide measurements by two assays utilizing antibodies with different epitope specificity
  

AACC 2009

• New insights into human proBNP processing
  
• New antibodies for dPAPP-A immunoassays
  

AACC 2008

• Processing of proBNP is affected by threonine 71 glycosylation
  
• Immunohistochemical identification of PAPP-A in human atherosclerotic plaques
  
• Immunochemical properties of PAPP-A from human atherosclerotic coronary arteris
  
• Different proBNP&NT-proBNP glycosylation: new regul. level in proBNP processing
  
• Development of sandwich immunoassays for measuring human adiponectin
  

AACC 2007

• Rec.proBNP Expressed in Eukaryotic Cells as Stable Standard for BNP Immunoassay
  
• ProBNP is a Major Form of BNP Immunoreactivity in Blood of Patients with HF
  
• Glycosylation of NT-proBNP Molecules and NT-proBNP Immunoassays
  

AACC 2005

• New sensitive sandwich assay for quantification of BNP in human blood
  
• NT-proBNP stability & immunoassays using MAbs with different epitope specifity
  
• Autoantibodies are associated with negative interference in cTnI assays
  

Other Hytest posters

• New type of TnI assay with reduced susceptibility to the presence of autoantibodies in blood sample
  
• Rubella Polyvalent Vaccine Candidate Based on Chimeric hsp70 Containing Constructs
  
• Sandwich immunoassays to detect adiponectin without cross-reactivity with complement component C1q
  
• PAPP-A from human atherosclerotic plaques is an active enzyme that cleaves IGFBP-4
  

Other posters

• Reference Range Study Using a High Sensitivity cTnI Assay in Development for the Sgx Clarity™ System
  
• BNP Assay in Development for the Sgx Clarity™ System Demonstrates Increased Clinical Sensitivity Relative to a Conventional BNP Immunoassay